Northwire Canada EditionThursday, July 23, 2026
Sign inSubscribe
Northwire
⌕
VZZ 0.180 +2.9% BMR 0.145 +3.6% NVO 0.055 −8.3% PMET 4.47 +2.0% CTG 0.125 +13.6% AVU 0.040 +0.0% SGML 14.32 −3.1% WRLG 0.720 +1.4% CAN 0.065 +8.3% ABRA 15.63 +1.6% LSTR 0.060 +0.0% OLA 13.10 +2.5% EQX 13.15 +2.7% SRA 0.780 +0.0% UTWO 0.390 −13.3% IVN 10.64 −1.2% VZZ 0.180 +2.9% BMR 0.145 +3.6% NVO 0.055 −8.3% PMET 4.47 +2.0% CTG 0.125 +13.6% AVU 0.040 +0.0% SGML 14.32 −3.1% WRLG 0.720 +1.4% CAN 0.065 +8.3% ABRA 15.63 +1.6% LSTR 0.060 +0.0% OLA 13.10 +2.5% EQX 13.15 +2.7% SRA 0.780 +0.0% UTWO 0.390 −13.3% IVN 10.64 −1.2%

Healthcare

Page 133
  1. Aug 22, 2025 · 17:27 · APS

    Aptose Biosciences appoints Ernst & Young auditor

    Aptose Biosciences appoints Ernst & Young auditor

    01
  2. Aug 22, 2025 · 16:37 · SEGN

    Reem Capital, Kalron close receipt financings

    Reem Capital, Kalron close receipt financings

    02
  3. Aug 22, 2025 · 15:50 · SURE

    Surenano arranges debt settlement, private placement

    Surenano arranges debt settlement, private placement

    03
  4. Aug 22, 2025 · 13:20 · AIDR

    Rocket Doctor closes $4.23-million private placement

    Rocket Doctor closes $4.23-million private placement

    04
  5. Aug 22, 2025 · 04:14 · NGMD

    Nugen introduces needle-free injection system

    Nugen introduces needle-free injection system

    05
  6. Aug 21, 2025 · 20:54 · PHA

    Premier Health loses $3.53-million in Q3

    Premier Health loses $3.53-million in Q3

    06
  7. Aug 21, 2025 · 17:33 · BHC

    Bausch's Cabtreo acne drug on two provincial drug plans

    Bausch's Cabtreo acne drug on two provincial drug plans

    07
  8. Aug 21, 2025 · 16:45 · RX

    BioSyent Releases Financial Results for Q2 and H1 2025

    BioSyent Releases Financial Results for Q2 and H1 2025

    08
  9. Aug 21, 2025 · 07:00 · COV

    Covalon Reports Strong Sequential Quarter on Quarter and Trailing Twelve Months Performance

    Covalon Reports Strong Sequential Quarter on Quarter and Trailing Twelve Months Performance

    09
  10. Aug 20, 2025 · 19:36 · NRX

    Nurexone releases preclinical ExoPTEN imaging results

    Nurexone releases preclinical ExoPTEN imaging results

    10
  11. Aug 20, 2025 · 18:28 · VHI

    Vitalhub closes $74.75-million bought deal offering

    Vitalhub closes $74.75-million bought deal offering

    11
  12. Aug 20, 2025 · 17:40 · HLS

    HLS Therapeutics obtains $107M in credit facilities

    HLS Therapeutics obtains $107M in credit facilities

    12
  13. Aug 20, 2025 · 17:30 · MPH

    Medicure Reports Financial Results for Quarter Ended June 30, 2025

    Medicure Reports Financial Results for Quarter Ended June 30, 2025

    13
  14. Aug 20, 2025 · 16:52 · HEM

    Hemostemix talks social media, IR programs

    Hemostemix talks social media, IR programs

    14
← Newer Older →